Consistent with this notion, Blombery and colleagues found a case of venetoclax-resistant CLL that lacked detectable BCL2 mutations, but had high levels of BCL-XL [15]. This evidence concerns the gene BCL2L1 and B-cell chronic lymphocytic leukemia.